Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants

202316 citationsJournal Articlehybrid Open Access

Authors

K. Ivar Lönnberg · University of Helsinki

Aleksi Tornio · Turku University Hospital

Päivi Hirvensalo · University of Helsinki

Jenni E. Keskitalo · Helsinki University Hospital

Anna-Liina Mustaniemi · University of Helsinki

Johanna I. Kiiski · University of Helsinki

Anne M. Filppula

Abstract

The current results can inform pharmacogenetic statin prescribing guidelines and show feasibility for the methodology to be used in larger future studies.

Topics & Keywords

Lipoproteins and Cardiovascular Health Drug Transport and Resistance Mechanisms Cholesterol and Lipid Metabolism

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Pharmacogenetics and Genomics

Volume 33, Issue 7, pp. 153-160

DOI: 10.1097/fpc.0000000000000504

Field-Weighted Citation Impact: 5.08